A Novel AHI-1-BCR-ABL-JAK2 Interaction Complex Mediates Cellular Resistance to Tyrosine Kinase Inhibitors in CML von DeGeer, Donna, Newmarch, Kathleen, Zhou, Leon, Chen, Min, Saw, Kyi Min, Turhan, Ali G, Jiang, Xiaoyan

Volltext

Combined Targeting of BCR-ABL and JAK2 with ABL and JAK2 Inhibitors Is Effective Against CML Patients' Leukemic Stem/Progenitor Cells von DeGeer, Donna, Gallipoli, Paolo, Chen, Min, Sloma, Ivan, Jorgensen, Heather, Forrest, Donna, Lambie, Karen, Nakamoto, Helen, Saw, Kyi Min, Chan, Matthew, Newmarch, Kathleen, Zhou, Leon, Turhan, Ali G., Arlinghaus, Ralph B., Eaves, Allen C., Eaves, Connie J., Holyoake, Tessa L., Jiang, Xiaoyan

Volltext